Time-Restricted eating tested as kidney disease therapy

NCT ID NCT06618859

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot study tests whether time-restricted eating (eating all meals within an 8-hour window each day) can reduce protein in the urine and slow kidney function decline in people with moderate chronic kidney disease. Fifty adults with stage 2-3 CKD and elevated albuminuria will follow either the 8-hour eating plan or their usual eating pattern for 12 weeks. Researchers will measure changes in kidney markers, blood pressure, body composition, and safety.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
time-restricted eating (behavioral intervention)
What this could lead to
If successful, this could point toward a simple dietary strategy to help manage chronic kidney disease and reduce protein leakage.
What could go wrong
This is a small pilot study with only 50 participants, so results may not apply broadly. Dietary changes can be hard to maintain, and the effect on kidney function may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RENAL INSUFFICIENCY, CHRONIC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University Hospital, Geneva

    RECRUITING

    Geneva, 1211, Switzerland

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.